Pyrogens in parenteral pharmaceuticals

Pharmaceutical Technology

Volumn 24, Issue 4, 2000, Pages 26-34

  Grandics, Peter ^a  

^a Sterogene Bioseparations Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PYROGEN;

ARTICLE; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; IMMUNOSUPPRESSIVE TREATMENT; QUANTITATIVE ASSAY; RISK ASSESSMENT;

EID: 0034129087     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. G.F. Brooks, J.S. Butel, and L.N. Ornston, "Cell Structure," in Medical Microbiology, Jawetz, Melnick, and Adelbergs, Eds. (Appleton & Lange, 9th ed., 1991), pp. 7-31.
2. S.K. Sharma, "Review: Endotoxin Detection and Elimination in Biotechnology," Biotechnol. Appl Biochem. 8, 5-22 (1986).
3. G.B. Harding et al., "Endotoxin and Bacterial Contamination of Dialysis Center Water and Dialysate: A Cross-Sectional Survey," Int. J. Artif. Organs 13 (1), 39-43 (1990).
4. P.S. Tobias, K. Soldau, and R.J. Ulevitch, "Identification of a Lipid A Binding Site in the Acute Phase Reactant Lipopolysaccharide Binding Protein," J. Biol. Chem. 284 (18), 10867-10871 (1989).
5. R.R. Schumann et al., "Structure and Function of Lipopolysaccharide Binding Protein," Science 249, 1429-1431 (1990).
6. G. Ramadori et al., "Lipopolysaccharide Binding: Biosynthesis of Lipopolysaccharide-Binding Protein in Rabbit Hepatocytes," Pathobiology 58, 89-94 (1990).
7. H.A. Pereira et al., "The Ontogeny of a 57-Kd Cationic Antimicrobial Protein of Human Polymorphonuclear Leukocytes: Localization to a Novel Granule Population," Blood 76 (4), 825-834 (1990).
8. M.N. Marra et al., "The Role Of Bactericidal/Permeability-Increasing Protein as a Natural Inhibitor of Bacterial Endotoxin," J. Immunol. 148 (2), 532-537 (1992).
9. S.D. Wright et al., "CD 14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein," Science 249, 1431-1433 (1990).
10. B. Sherry and A. Cerami, "Cachectin/Tumor Necrosis Factor Exerts Endocrine, Paracrine, and Attocrine Control of Inflammatory Responses," J. Cell Biol 107, 1269-1277 (1988).
11. C.A. Dinarello, "Interleukin-1 and Its Biologically Related Cytokines," Adv. Immunol. 44, 153-205 (1989).
12. C.A. Dinarello and S.M. Wolff, "The Role of Interleukin-1 in Disease," N. Engl. J. Med. 328, 106-113 (14 January 1993).
13. J. Bergstrom et al., "Elevated Serum C-Reactive Protein Is a Strong Predictor of Increased Mortality and Low Serum Albumin in Hemodialysis (HD) Patients," J. Am. Soc. Nephrol. 6, 573 (1995).
14. A. Mahiout, "Production of Endotoxin and Its Related Subfragments in Contaminated Bicarbonate Dialysate," J. Am. Soc. Nephrol. 2, 337 (1991).
15. P.P. Massion et al., "Novel Pseudomonas Product Stimulates Interleukin-8 Production in Airway Epithelial Cells In Vitro," J. Clin. Invest. 93, 26-32 (1994).
16. USP 23/NF 18, Biological Tests, 〈85〉 Bacterial Endotoxin Test and 〈151〉 Pyrogen Test (The United States Pharmacopeial Convention, Rockville, MD, 1995).
17. European Pharmacopoeia, Biological Tests, 2.6.8 Pyrogens and 2.6.14 Bacterial Endotoxins (Council of Europe, Strasbourg, 3d ed., 1997).
18. Y.S. Taktak et al., "Assay of Pyrogens by Interleukin-6 Release from Monocytic Cell Lines," J. Pharm. Pharmacol. 43, 578-582 (1990).
19. C.A. Dinarello et al., "Human Leukocytic Pyrogen Test for Detection of Pyrogenic Material in Growth Hormone Produced by Recombinant Escherichia coli," J. Clin. Microbiol. 20 (3), 323-329 (1984).
20. W.P. Arend et al., "IL-1-β Production in Cultured Human Monocytes Is Regulated at Multiple Levels," J. Immunol. 143 (1), 118-126 (1989).
21. S. Poole et al., "Detection of Pyrogens by Cytokine Release," Lancet 130 (16 January 1988).
22. T.M. Lukkassen, "An Investigation into the Causes of Pyrogenic Reactions in Haemodialysis and Haemodiafiltration Patients," a Thesis submitted to the University of Oslo, Norway, for the degree of Candidata Pharmaciae (December 1997).
23. H.W.L. Ziegler-Heitbrock et al., "Establishment of a Human Cell Line (Mono-Mac-6) with Characteristics of Mature Monocytes," Int. J. Cancer 41 (3), 456-461 (1988).
24. S. Tsuchiya et al., "Establishment and Characterization of a Human Acute Monocytic Leukemia Cell Line (THP-1)," Int. J. Cancer 26 (2), 171-176 (1980).
25. H. Baumann and J. Gauldie, "The Acute-Phase Response," Immunol. Today 15 (2), 74-80 (1994).
26. M.J. Dascombe, "The Pharmacology of Fever," Prog. Neurobiol. 25, 327-373 (1985).
27. G. Lukeshi and N. Rothwell, "Cytokines and Fever," Int. Arch. Allergy Immunol. 109, 301-307 (1996).
28. J.E. Perillo, "Pathogenetic Mechanisms of Septic Shock," New Engl. J. Med. 328, 1471-1477 (1993).
29. L.S. Young, "Gram-Negative Sepsis," in Principles and Practice of Infectious Diseases, G.L. Mendell, R.G. Douglas, Jr., and J.E. Bennett, Eds. (Churchill Livingston, New York, 3d ed., 1990), pp. 611-636.
30. E.V. Granowitz et al., "Intravenous Endotoxin Suppresses the Cytokine Response of Peripheral Blood Mononuclear Cells of Healthy Humans," J. Immunol. 151 (3), 1637-1645 (1993).
31. H.D. Hochstein et al., "Properties of US Standard Endotoxin (EC-5) in Human Male Volunteers," J. Endotoxin Res. 1, 52-56 (1994).
32. S. Krautzig et al., "New Indicators to Evaluate Bacteriological Quality of the Dialysis Fluid and the Associated Inflammatory Response in ESRD Patients," Nephrol. Dialysis Transpl. 11 (Suppl. 2), 87-91 (1996).
33. M. Colucci et al., "Cultured Human Endothelial Cells Generate Tissue Factor in Response to Endotoxin," J. Clin. Invest. 71, 1893-1896 (1983).
34. K.L. Moore et al., "Endotoxin Enhances Tissue Factor and Suppresses Thrombomodulin Expression of Human Vascular Endothelium In Vitro," J. Clin. Invest. 79, 124-130 (1987).
35. J.E. Kaplan et al., "Platelets Adhere to Thrombin-Treated Endothelial Cells In Vitro," Am. Physiol Soc. 257, H423-H433 (1989).
36. H. Lindner et al., "Peripheral Blood Mononuclear Cells Induce Programmed Cell Death in Human Endothelial Cells and May Prevent Repair: Role of Cytokines," Blood 89 (6), 1931-1938 (1997).
37. G. Eissner et al., "Critical Involvement of Transmembrane Tumor Necrosis Factor-α in Endothelial Programmed Cell Death Mediated by Ionizing Radiation and Bacterial Endotoxin," Blood 86 (11), 4184-4193 (1995).
38. G. Lonnemann et al., "Permeability of Dialyzer Membranes to TNF-α-Inducing Substances Derived from Water Bacteria," Kidney Int. 42, 61-68 (1992).
39. M. Frater-Schroder et al., "Transforming Growth Factor-β Inhibits Endothelial Cell Proliferation," Biochem. Biophys. Res. Commun. 137 (1), 295-302 (1986).